Kimani, Stanley; Shmigol, Tatiana; Hammond, Sam; Phillips, James; Bruce, James; MacRobert, Alexander; Malakhov, Mikhail and Golding, Jon
This is the latest version of this eprint.
|DOI (Digital Object Identifier) Link:||http://dx.doi.org/doi:10.1111/j.1751-1097.2012.01204.x|
|Google Scholar:||Look up in Google Scholar|
Phthalocyanine photosensitizers are effective in anticancer photodynamic therapy (PDT) but suffer from limited solubility, limited cellular uptake, and limited selectivity for cancer cells. In order to improve these characteristics, we synthesized isopropylidene-protected and partially deprotected tetra β-glycosylated zinc (II) phthalocyanines and compared their uptake and accumulation kinetics, subcellular localization, in vitro photocytotoxicity, and reactive oxygen species generation to those of disulfonated aluminium phthalocyanine. In MCF-7 cancer cells, one of the compounds, Zinc phthalocyanine , demonstrated ten-fold higher uptake, five-fold greater PDT-induced cellular reactive oxygen species concentration, and two-fold greater phototoxicity than equimolar (9 μM) disulfonated aluminium phthalocyanine. Thus, isopropylidene-protected β-glycosylation of phthalocyanines provides a simple method of improving the efficacy of photodynamic therapy.
|Item Type:||Journal Article|
|Copyright Holders:||2012 Wiley Periodicals, Inc., 2012 The American Society of Photobiology|
Science > Life, Health and Chemical Sciences
|Depositing User:||Jon Golding|
|Date Deposited:||26 Jul 2012 08:23|
|Last Modified:||14 Nov 2012 11:51|
Available Versions of this Item
- Fully protected glycosylated Zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells. (deposited 26 Jul 2012 08:23) [Currently Displayed]
Actions (login may be required)
|Public: Report issue / request change|